医学
风湿性多肌痛
强的松
安慰剂
内科学
不利影响
糖皮质激素
胃肠病学
外科
巨细胞动脉炎
血管炎
替代医学
疾病
病理
作者
Robert Spiera,Sebastian Unizony,Kenneth J. Warrington,Jennifer Sloane,Angeliki Giannelou,Michael C. Nivens,Bolanle Akinlade,Wanling Wong,Rafia Bhore,Yong Lin,Frank Buttgereit,Valérie Devauchelle‐Pensec,Andrea Rubbert‐Roth,George D. Yancopoulos,Frédéric Marrache,Naimish Patel,Bhaskar Dasgupta
标识
DOI:10.1056/nejmoa2303452
摘要
Sarilumab showed significant efficacy in achieving sustained remission and reducing the cumulative glucocorticoid dose in patients with a relapse of polymyalgia rheumatica during glucocorticoid tapering. (Funded by Sanofi and Regeneron Pharmaceuticals; SAPHYR ClinicalTrials.gov number, NCT03600818.).
科研通智能强力驱动
Strongly Powered by AbleSci AI